- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
Patent holdings for IPC class A61K 31/549
Total number of patents in this class: 491
10-year publication summary
|
47
|
53
|
46
|
34
|
44
|
25
|
34
|
34
|
29
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| CorMedix Inc. | 58 |
27 |
| Achillion Pharmaceuticals, Inc. | 159 |
24 |
| Soleno Therapeutics, Inc. | 35 |
22 |
| The George Institute for Global Health | 31 |
14 |
| Merck Sharp & Dohme LLC | 3729 |
12 |
| Geistlich Pharma AG | 158 |
11 |
| Idorsia Pharmaceuticals Ltd. | 331 |
9 |
| Bristol-myers Squibb Company | 4811 |
7 |
| Takeda Pharmaceutical Company Limited | 2718 |
7 |
| Daiichi Sankyo Company, Limited | 1886 |
7 |
| The General Hospital Corporation | 4827 |
6 |
| Children's Medical Center Corporation | 1930 |
6 |
| Merck Sharp & Dohme Corp. | 2184 |
5 |
| Pfizer Inc. | 3367 |
5 |
| Mayo Foundation for Medical Education and Research | 3355 |
5 |
| Emory University | 1703 |
5 |
| Regents of the University of Minnesota | 2770 |
5 |
| Theaprin Pharmaceuticals Inc. | 32 |
5 |
| Vasthera Co. Ltd. | 16 |
5 |
| Novartis AG | 10327 |
4 |
| Other owners | 300 |